Amryt Pharma（LON: AMYT）股票跌破五十天移动平均线143.00美元

Amryt Pharma plc (LON:AMYT – Get Rating)'s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 143 ($1.74) and traded as low as GBX 143 ($1.74). Amryt Pharma shares last traded at GBX 143 ($1.74), with a volume of 90,727 shares.

Amryt Pharma Trading Down 11.7 %

The company has a 50-day moving average price of GBX 143 and a 200-day moving average price of GBX 143. The firm has a market capitalization of £457.11 million and a price-to-earnings ratio of -4.33. The company has a debt-to-equity ratio of 66.05, a quick ratio of 1.14 and a current ratio of 1.80.

Amryt Pharma Company Profile

(Get Rating)

Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.

Read More

• This Small Tech With Big Growth Prospects Is Nearing A Buy Point
• Don't Chase FedEx Higher, Wait For The Pullback
• 3 Stocks For A Defensive Tech Portfolio
• Milk the Dividends on These 3 Cash Cows
• Europe Raises Interest Rates, Should the Fed Follow?

Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.